Past executives haven't been paid what they think they're owed and there is a dispute with geological consultants resulting in us not receiving some assay results from the cobalt drilling. I suppose they haven't been paid either, or we would surely have our assay results is my reading.
My close interest in the cobalt aquisitions from the outset of them coming into the company, it's the thing that first attracted me to the company after receiving a Hot Copper advertising email, makes me suspect it may have been a bit of a dodgy play from the very beginning. ASIC have recently begun a crackdown on and investigation into brokers allocating shares in IPO'S to themselves and their staff for the purposes of trading games. Officers of both this company and the broker made comments to me which were unsettling just prior to our first AGM, which is why I attended and asked the only question on the day.
People I contacted about the mooted cobalt IPO seemed to me be very arrogantly loose at the mouth over things that did not seem quite right and seeing as past executives of the company have had to lodge legal claims over monies they consider owed to them I suspect they might be susceptible to coming clean with their own opinions in the future regarding that.
This Board of Directors has been party to acrimonious court procedings between fellow board members before, at ATU and are again now with this company. There is also, as mentioned, an acrimonious relationship with our geological
consultants resulting in us not even receiving assay results.
That's what I picked up. Plus there's no mention of the legal challenge to our claims at Cancet.
Is it a personality problem perhaps?
- Forums
- ASX - By Stock
- MTC
- Ann: Half Yearly Report and Accounts
MTC
metalstech limited
Add to My Watchlist
3.85%
!
13.5¢

Ann: Half Yearly Report and Accounts, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $28.17M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $3.713K | 27.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 0.130 |
4 | 44619 | 0.125 |
3 | 138341 | 0.120 |
1 | 10000 | 0.100 |
1 | 10500 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 1000 | 1 |
0.140 | 22528 | 3 |
0.145 | 126965 | 4 |
0.150 | 50000 | 1 |
0.155 | 35745 | 1 |
Last trade - 14.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MTC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online